Kymab makes two senior appointments
June 5, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing arkinstall, clark, kymab
Cambridge-based biopharma firm Kymab has hired Steve 
Arkinstall as a chief scientific officer, and Nigel Clark as VP 
and head …
NHS Confederation: ‘ring-fence NHS funding’
June 5, 2014Sales and Marketing Mid Staffs, NHS Confederation, Rob webster, UK
The boss of the NHS Confederation has challenged political parties to ring-fence NHS funding for the next ten years. Rob …
Robert Francis QC joins Care Quality Commission
June 4, 2014Sales and Marketing Hunt, Mid Staffs, NHS, UK, rew, robert francis
Robert Francis QC is to join health watchdog the Care Quality Commission (CQC) as a non-executive director. Francis will be …
Apple follows Samsung into e-health
June 4, 2014Medical Communications, Sales and Marketing Apple, Samsung, digital, healthkit, ios8, wearable
Apple has followed Samsung into the e-health arena by unveiling HealthKit, a new platform that allows users to pool their …
Bayer’s chief executive to step down in 2016
June 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Germany, Marijn Dekkers
Marijn Dekkers the chief executive of German pharma firm Bayer has set his departure date to the end of 2016. …
Lilly the latest to open up data
June 4, 2014Medical Communications, Research and Development, Sales and Marketing Goldacre, NHS, alltrials, data, lilly, transparency, trials
Eli Lilly is to begin sharing its clinical trial data with scientific researchers through a website housing information from several …
New chief scientific officer for Pfizer
June 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Morris Birnbaum, Pfizer
Dr Morris Birnbaum has joined Pfizer as its chief scientific officer for cardiovascular and metabolic disease research. Based in Cambridge …
Merck drug shines at ASCO
June 4, 2014Research and Development, Sales and Marketing ASCO, Cancer, FDA, MK-3475, Merck, melanoma
Merck has shown off one of its investigative cancer drug’s impressive results in advanced head and neck cancer at ASCO …
Health select committee chairman resigns
June 3, 2014Medical Communications, Sales and Marketing Conservative, NHS, Stephen Dorrell, health secretary, lankly, reforms
The Conservative MP for Charnwood Stephen Dorrell who has chaired the health select committee since 2010, has resigned. The unexpected …
China manufacturing slips in May
June 3, 2014Manufacturing and Production China, hsbc, manufacturing, pmi
Activity in China’s manufacturing sector slipped slightly in May, according to figures from HSBC, with the bank suggesting that the …
Novartis hires Merck president to lead oncology
June 3, 2014Medical Communications, Research and Development, Sales and Marketing Bruno Strigini, MSD, Merck, Novartis, oncology
Novartis has hired Merck’s president of Europe and Canada Bruno Strigini to be its president of oncology. The role was …
Boehringer lung cancer drug shows survival benefit
June 3, 2014Sales and Marketing ASCO, Boehringer, NSCLC, afatinib, giotrif, lung cancer
A new analysis of two late-stage trials shows that Boehringer drug Giotrif extends overall survival in a large proportion of …
GSK signs Adaptimmune deal
June 3, 2014Manufacturing and Production, Research and Development, Sales and Marketing AZ, Adaptimmune, BMS, Cancer, GSK, oncology
GlaxoSmithKline has signed a deal to develop and commercialise biotech firm Adaptimmune’s lead clinical cancer programme with T-cell receptors (TCRs), …
Patricell appoints business development specialist
June 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing patricell, robertshaw
Nottingham-based life sciences supplier firm Patricell has appointed an experienced business development manager in Lucy Robertshaw. Robertshaw has years of …
Cialis OTC approval sought
June 2, 2014Sales and Marketing Cialis, ED, OTC, Sanofi, lilly
Sanofi and Eli Lilly have announced they are to push ahead with plans to seek regulatory approval for erectile dysfunction …
Lemtrada resubmitted to FDA
June 2, 2014Sales and Marketing FDA, Lemtrada, MS, Sanofi
Sanofi has resubmitted its application for Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis (MS) to the …
Masters Speciality Pharma hires two
June 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing masters, mosa, rosetti
UK-based pharma supply firm Masters Speciality Pharma has made two new key appointments to strengthen its team. Ivan Rosetti (pictured) …
David Haslam: NICE, drug pricing and ethics
June 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chairman, Dillon, NHS, NICE, adams, has lam
Since 2010, I have spent a great deal of time of writing about NICE, covering nearly all of all its …
ASCO 2014: old dogs, new tricks top the bill
June 2, 2014Research and Development, Sales and Marketing ASCO, Cancer, chicago, docetaxel, exemestane
Research showing the effectiveness of established cancer treatments in new settings is taking centre stage at this year’s American Society …
Italy eyes €1.2 billion pharma fine
May 30, 2014Sales and Marketing Novartis, Roche, avastin, off label, wet and
Italy’s health ministry says it is looking for €1.2 billion in damages from Roche and Novartis over claims that the …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
